Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser

NAUnknownINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Major Depressive Disorder
Interventions
DEVICE

Near-infrared Transcranial Laser Therapy

The treatment consists in exposing bilaterally the frontal brain to Transcranial Laser Therapy, which may enhance ATP production in depressed subjects.

Trial Locations (1)

15007

RECRUITING

Hospital Nacional Hipolito Unanue, Lima

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NeuroThera

INDUSTRY

lead

Peruvian Clinical Research

OTHER

NCT05435820 - Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser | Biotech Hunter | Biotech Hunter